Cargando…
P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430973/ http://dx.doi.org/10.1097/01.HS9.0000971592.88393.d2 |
| _version_ | 1785091088008085504 |
|---|---|
| author | Zhi-Ming, LI Sun, Peng Cen, Hong Yang, Hai-Yan Huang, Rui Cai, Zhen Gu, Xue-Kui |
| author_facet | Zhi-Ming, LI Sun, Peng Cen, Hong Yang, Hai-Yan Huang, Rui Cai, Zhen Gu, Xue-Kui |
| author_sort | Zhi-Ming, LI |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430973 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309732023-08-17 P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY Zhi-Ming, LI Sun, Peng Cen, Hong Yang, Hai-Yan Huang, Rui Cai, Zhen Gu, Xue-Kui Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430973/ http://dx.doi.org/10.1097/01.HS9.0000971592.88393.d2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zhi-Ming, LI Sun, Peng Cen, Hong Yang, Hai-Yan Huang, Rui Cai, Zhen Gu, Xue-Kui P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY |
| title | P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY |
| title_full | P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY |
| title_fullStr | P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY |
| title_full_unstemmed | P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY |
| title_short | P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY |
| title_sort | p1174: pi3k inhibitor linperlisib combined with gemcitabine and oxalipatin (gemox) in relapsed and/or refractory dlbcl: analysis based on tumor biology |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430973/ http://dx.doi.org/10.1097/01.HS9.0000971592.88393.d2 |
| work_keys_str_mv | AT zhimingli p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT sunpeng p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT cenhong p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT yanghaiyan p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT huangrui p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT caizhen p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT guxuekui p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology |